Page last updated: 2024-11-08

thiacremonone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

thiacremonone: results suggest that a sulfurocompound from garlic inhibited colon cancer cell growth through induction of apoptotic cell death by modulating of NF-kappaB; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID539170
CHEBI ID177511
SCHEMBL ID13240952
MeSH IDM0515313

Synonyms (15)

Synonym
CHEBI:177511
2,4-dihydroxy-2,5-dimethylthiophen-3-one
2,4-dihydroxy-2,5-dimethyl-3(2h)-thiophenone
2,5-dimethyl-2,4-dihydroxy-3(2h)-thiophenone
SCHEMBL13240952
JYMIRUWYSKOKRU-UHFFFAOYSA-N
2,4-dihydroxy-2,5-dimethyl-3(2h)-thiophenone #
thiacremonone
96504-28-8
2,4-dihydroxy-2,5-dimethyl-2,3-dihydrothiophen-3-one
2,4-dihydroxy-2,5-dimethyl-3(2h)-thiophenone, 9ci
2,5-dimethyl-2,4-dihydroxy-2,3-dihydrothiophen-3-one
AT21857
2,4-dihydroxy-2,5-dimethylthiophen-3(2h)-one
DTXSID601317711

Research Excerpts

Treatment

Thiacremonone significantly attenuated cognitive impairments in amyloid precursor protein (APP)/presenilin 1 (PS1) double-mutant transgenic mice.

ExcerptReferenceRelevance
"The thiacremonone-treated db/db mice showed a loss of body weight and decrease in blood triglyceride and glucose levels compared with the control mice."( Antiobesity effects of a sulfur compound thiacremonone mediated via down-regulation of serum triglyceride and glucose levels and lipid accumulation in the liver of db/db mice.
Ban, JO; Cho, MC; Hong, JT; Jeong, HS; Kang, JW; Kim, EJ; Kim, JW; Kim, MS; Lee, DH; Yang, Y; Yoon, DY, 2012
)
1.13
"Treatment of thiacremonone significantly attenuated cognitive impairments in amyloid precursor protein (APP)/presenilin 1 (PS1) double-mutant transgenic mice."( Thiacremonone Potentiates Anti-Oxidant Effects to Improve Memory Dysfunction in an APP/PS1 Transgenic Mice Model.
Han, SB; Hong, JT; Hwang, BY; Hwang, J; Jeong, HS; Jin, P; Jung, JK; Kim, EC; Oh, KW; Park, KR; Yun, HM, 2016
)
2.23
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
secondary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing one hydrogen and one organyl group. Secondary alpha-hydroxy ketones are also known as acyloins, and are formally derived from reductive coupling of two carboxylic acid groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]